Vanguard Group Inc Immucell Corp Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Immucell Corp stock. As of the latest transaction made, Vanguard Group Inc holds 308,702 shares of ICCC stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308,702

Previous 225,595 36.84%

Holding current value

$2.05 Million

Previous $1.08 Million 98.89%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$4.81 - $7.6 $399,744 - $631,613	83,107 Added 36.84%	308,702 $2.15 Million
Q2 2024 Aug 13, 2024	BUY	$4.18 - $5.48 $38,740 - $50,788	9,268 Added 4.28%	225,595 $1.09 Million
Q1 2024 May 10, 2024	BUY	$4.73 - $5.47 $45,980 - $53,173	9,721 Added 4.71%	216,327 $1.15 Million
Q4 2023 Feb 14, 2024	BUY	$4.45 - $5.47 $6,715 - $8,254	1,509 Added 0.74%	206,606 $1.05 Million
Q3 2023 Nov 14, 2023	SELL	$4.53 - $5.61 $5,562 - $6,889	-1,228 Reduced 0.6%	205,097 $1.1 Million
Q4 2022 Feb 10, 2023	BUY	$6.09 - $8.25 $21,899 - $29,667	3,596 Added 1.77%	206,325 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$7.04 - $9.1 $7,040 - $9,100	-1,000 Reduced 0.49%	202,729 $1.52 Million
Q2 2022 Aug 12, 2022	SELL	$7.7 - $10.71 $4,589 - $6,383	-596 Reduced 0.29%	203,729 $1.77 Million
Q1 2022 May 13, 2022	BUY	$8.0 - $10.06 $296,648 - $373,034	37,081 Added 22.17%	204,325 $1.97 Million
Q4 2021 Feb 14, 2022	BUY	$8.0 - $9.74 $160,064 - $194,877	20,008 Added 13.59%	167,244 $1.34 Million
Q2 2021 Aug 13, 2021	BUY	$8.5 - $10.95 $1.25 Million - $1.61 Million	147,236 New	147,236 $1.4 Million

Others Institutions Holding ICCC

# of Institutions

Shares Held

1.31M

Call Options Held

Put Options Held

View Full List

About IMMUCELL CORP

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $51.5M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

More about ICCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Immucell Corp Transaction History